Trial Profile
Comparative study between sugammadex and neostigmine for the reversal of neuromuscular block in pediatric patients undergoing lower abdominal surgeries
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2018
Price :
$35
*
At a glance
- Drugs Atropine (Primary) ; Neostigmine (Primary) ; Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 20 Feb 2017 Status changed from not yet recruiting to completed, according to results published in the Acta Anaesthesiologica Scandinavica.
- 10 Feb 2017 Primary endpoint of recovery time has been met, according to results published in the Acta Anaesthesiologica Scandinavica.
- 10 Feb 2017 Results published in the Acta Anaesthesiologica Scandinavica